{"id":548189,"date":"2021-06-17T17:34:01","date_gmt":"2021-06-17T17:34:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=548189"},"modified":"2021-06-17T17:34:01","modified_gmt":"2021-06-17T17:34:01","slug":"astigmatism-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-novartis-ag-seavision-usa-johnson-johnson-and-many-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/astigmatism-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-novartis-ag-seavision-usa-johnson-johnson-and-many-others_548189.html","title":{"rendered":"Astigmatism Market: Industry Analysis, Key Companies, Emerging Drugs and Treatment by DelveInsight | Novartis AG, SeaVision USA, Johnson &#038; Johnson, and Many Others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1623908808.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Astigmatism Market: Industry Analysis, Key Companies, Emerging Drugs and Treatment by DelveInsight | Novartis AG, SeaVision USA, Johnson &amp; Johnson, and Many Others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1623908808.jpeg\" alt=\"Astigmatism Market: Industry Analysis, Key Companies, Emerging Drugs and Treatment by DelveInsight | Novartis AG, SeaVision USA, Johnson &amp; Johnson, and Many Others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Astigmatism Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astigmatism-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Astigmatism<\/a><\/strong> is a common vision condition that causes blurred vision. It occurs when the cornea (the clear front cover of the eye) is irregularly shaped or sometimes because of the curvature of the lens inside the eye and is also known as corneal astigmatism, which is the main type of astigmatism.<\/p>\n<p style=\"text-align: justify;\">Astigmatism is hereditary and is usually present from birth. In some cases, the curvature of the lens inside the eye can change, resulting in an increase or decrease in astigmatism. This is called lenticular astigmatism, to differentiate it from the more common corneal astigmatism. This change frequently occurs in adulthood and can precede the development of naturally occurring cataracts.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s<strong>&nbsp;&#8220;Astigmatism Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong>&nbsp;report delivers an in-depth understanding of the Astigmatism, historical and forecasted epidemiology as well as the Astigmatism market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some facts of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astigmatism-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Astigmatism Market<\/a>:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>As per a study conducted by Knyazer et. al., (2019) titled &ldquo;Prevalence of astigmatism before routine cataract surgery: comparison between bedouin and jewish population in southern Israel&rdquo;, more than 25% of patients had astigmatism more than 1.5D. Higher astigmatism was found in men than in women (1.24D vs.1.15D p- value = 0.04) of study group.<\/li>\n<li>Ore et al., (2014) conducted a cross-sectional population-based study titled &ldquo;Factors influencing prevalence of vision and ocular abnormalities among Jewish and Arab Israeli schoolchildren&rdquo;, among 2113 students aged 6-7 and 13-14 years old and found a higher prevalence of myopia and astigmatism among the 13-14 year olds. The total prevalence of astigmatism among the study population was 4.7% and its was 1.76 times more prevalent among 13-14 years old students.<\/li>\n<li>According to an article published by OMICS International Journals titled &ldquo;Astigmatism&rdquo;, the prevalence of astigmatism in Israel, from data of medical examinations of an unselected population of 312,149 subjects ages 17 to 19 years, astigmatism in both eyes was found in 16.27% of the population. The prevalence of astigmatism was 1.69%. The various errors of astigmatism were more common among females.<\/li>\n<li>According to secondary sources, Astigmatism could have a similar incidence\/prevalence in females and males<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/astigmatism-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/astigmatism-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Astigmatism Companies<\/strong><strong> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Novartis AG<\/li>\n<li>SeaVision USA<\/li>\n<li>Johnson &amp; Johnson<\/li>\n<li>Bausch &amp; Lomb Incorporated<\/li>\n<li>CooperVision<\/li>\n<li>Orion Vision Group<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/astigmatism-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/astigmatism-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the <\/strong><strong>Astigmatism Market Report<\/strong><strong>:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Astigmatism, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Astigmatism epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Astigmatism are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Astigmatism market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Astigmatism market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astigmatism-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Astigmatism Therapies<\/a><\/strong><strong> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Clariti 1day<\/li>\n<li>Biotrue ONEday<\/li>\n<li>Nano-Drops<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: https:\/\/www.delveinsight.com\/sample-request\/astigmatism-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Astigmatism<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Astigmatism<\/p>\n<p style=\"text-align: justify;\">4. Astigmatism: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Astigmatism: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Astigmatism Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Astigmatism Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Astigmatism: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Astigmatism<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About&nbsp;<\/strong><strong>DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.&nbsp; Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform&nbsp;PharmDelve.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=astigmatism-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-novartis-ag-seavision-usa-johnson-johnson-and-many-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/astigmatism-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/astigmatism-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/astigmatism-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=astigmatism-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-novartis-ag-seavision-usa-johnson-johnson-and-many-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astigmatism Market Astigmatism is a common vision condition that causes blurred vision. It occurs when the cornea (the clear front cover of the eye) is irregularly shaped or sometimes because of the curvature of the lens inside the eye and &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/astigmatism-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-novartis-ag-seavision-usa-johnson-johnson-and-many-others_548189.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-548189","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/548189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=548189"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/548189\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=548189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=548189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=548189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}